Earlier this month, Company CEO Ryoji Baba was officially invited by the Embassy of Japan in Vietnam and appointed as a Board Member of United Nations-affiliated non-governmental organization (“NGO”) ...
Presentations to highlight JADE101’s preclinical safety profile and translational framework guiding its clinical development in IgA nephropathy; JADE101 is an investigational, p ...
Vamikibart is the first non-steroid targeted therapy designed to address inflammation driving UME and may offer a potential new treatment option for patients; Vision improvements ...
ART6043 continues to be evaluated in a first-in-human Phase 1/2a study in patients with advanced solid tumors. ART6043 has the potential to advance into dedicated Phase 2 trials to assess efficacy ...
Silver Creek Pharmaceuticals Receives FDA Fast Track Designation for Scp776 in Acute Ischemic Stroke
Silver Creek also announced that its Phase II ARPEGGIO trial ( NCT05585606 ) evaluating scp776 in patients with acute ischemic stroke has completed enrollment. Topline results from the study will be ...
Valitor Appoints Biotech and Ophthalmic Industry Veteran Gregory D. Kunst as Chief Executive Officer
Valitor, a biotechnology company engineering a new generation of ophthalmic medicines, today announced the appointment of Gregory D. Kunst as chief executive officer and member of the board of ...
The growth of Wake Radiology’s breast imaging section coincides with the launch of its "We See the Difference" campaign, a Breast Cancer Awareness Month initiative aimed at educating women about the ...
Oryzon’s other ongoing clinical programs in CNS continue as planned. Vafidemstat is also currently being evaluated in a double-blind, randomized, placebo-controlled Phase IIb trial assessing its ...
These purchases are part of the share buy-back program of up to 200,000 Fagron shares to fulfill Fagron’s obligations under its long-term incentive scheme, which was announced on 9 October 2025. The ...
Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 ...
Boehringer Ingelheim reported positive results from the Beamion LUNG-1 trial evaluating zongertinib in treatment-naïve patients (N=74) with advanced non-small cell lung cancer (NSCLC) who have HER2 ...
New multi-year agreement continues Anthem members’ access to high-quality, affordable care ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback